Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides for the treatment of systemic lupus erythematosus

Peptides for the treatment of systemic lupus erythematosus

US Patent 6228363 · Granted May 8, 2001

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating type 1 diabetes by administering NKp46 polypeptide2015
Humanized antibodies specific for HSP65-derived peptide-6 methods and uses there2014
Adenylyl cyclase-associated protein (CAP1) and uses thereof as a target for immu2014
Method of treating diabetes by administering an anti-NKp46 antibody2013
B-cell epitope peptides of HSP 65, novel amino acid sequences, DNA encoding the 2012
Use of liposomal glucocorticoids for treating inflammatory states2010
B-cell epitope peptides of HSP 65, DNA encoding said peptides, antibodies direct2009
Amino acid sequences, DNA encoding the amino acid sequences, antibodies directed2007
B-cell epitope peptides of HSP 652004
Lupus disease immunoassay methods1998
Method for inhibiting heparanase activity1993
Method for decreasing tumor metastasis1989